<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
</head>

<body>
    <div class="container">
        <h1>Static outliers for NHS Sunderland CCG</h1>
        This is some intro text.

        <h2>Prescribing where NHS Sunderland CCG is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm">
  <thead>
    
    
  <tr><th>BNF Chemical</th><th>Chemical Items</th><th>BNF Subparagraph</th><th>Subparagraph Items</th><th>ratio</th><th>mean</th><th>std</th><th>z_score</th><th>plots</th></tr></thead>
  <tbody>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0801050AA&amp;denomIds=8.1.5&amp;selectedTab=summary">Imatinib Mesilate</a></th>
      <td>8</td>
      <td>Other Antineoplastic Drugs</td>
      <td>61</td>
      <td>0.13</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>69.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=1305020Z0&amp;denomIds=13.5.2&amp;selectedTab=summary">Cholesterol/Simvastatin</a></th>
      <td>2</td>
      <td>Preparations For Psoriasis</td>
      <td>4213</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>13.75</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0205051W0&amp;denomIds=2.5.5&amp;selectedTab=summary">Imidapril Hydrochloride</a></th>
      <td>432</td>
      <td>Angiotensin-Converting Enzyme Inhibitors</td>
      <td>195964</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>8.75</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=1301010I0&amp;denomIds=13.1.1&amp;selectedTab=summary">Wool Fat Hydrous</a></th>
      <td>1</td>
      <td>Vehicles</td>
      <td>2</td>
      <td>0.50</td>
      <td>0.02</td>
      <td>0.08</td>
      <td>5.79</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0803042R0&amp;denomIds=8.3.4&amp;selectedTab=summary">Degarelix</a></th>
      <td>588</td>
      <td>Prostate Cancer &amp; Gonadorelin Analogues</td>
      <td>2491</td>
      <td>0.24</td>
      <td>0.02</td>
      <td>0.04</td>
      <td>5.45</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  </tbody>
</table>

        <h2>Prescribing where NHS Sunderland CCG is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm">
  <thead>
    
    
  <tr><th>BNF Chemical</th><th>Chemical Items</th><th>BNF Subparagraph</th><th>Subparagraph Items</th><th>ratio</th><th>mean</th><th>std</th><th>z_score</th><th>plots</th></tr></thead>
  <tbody>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0801050P0&amp;denomIds=8.1.5&amp;selectedTab=summary">Hydroxycarbamide</a></th>
      <td>53</td>
      <td>Other Antineoplastic Drugs</td>
      <td>61</td>
      <td>0.87</td>
      <td>1.00</td>
      <td>0.02</td>
      <td>-6.05</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0406000T0&amp;denomIds=4.6&amp;selectedTab=summary">Prochlorperazine Maleate</a></th>
      <td>3740</td>
      <td>Drugs Used In Nausea And Vertigo</td>
      <td>26979</td>
      <td>0.14</td>
      <td>0.24</td>
      <td>0.03</td>
      <td>-3.16</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0206010F0&amp;denomIds=2.6.1&amp;selectedTab=summary">Glyceryl Trinitrate</a></th>
      <td>4726</td>
      <td>Nitrates</td>
      <td>42186</td>
      <td>0.11</td>
      <td>0.27</td>
      <td>0.05</td>
      <td>-3.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0501050B0&amp;denomIds=5.1.5&amp;selectedTab=summary">Clarithromycin</a></th>
      <td>2928</td>
      <td>Macrolides</td>
      <td>11787</td>
      <td>0.25</td>
      <td>0.58</td>
      <td>0.11</td>
      <td>-3.09</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr>
      <th><a href="https://openprescribing.net/analyse/#org=CCG&amp;orgIds=00P&amp;numIds=0205051R0&amp;denomIds=2.5.5&amp;selectedTab=summary">Ramipril</a></th>
      <td>57488</td>
      <td>Angiotensin-Converting Enzyme Inhibitors</td>
      <td>195964</td>
      <td>0.29</td>
      <td>0.67</td>
      <td>0.13</td>
      <td>-3.00</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAV4AAABkCAYAAADOvVhlAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAPYQAAD2EBqD+naQAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAMsUlEQVR4nO3deZAU5R3G8W8jh/eBUQQ1abzFYCxIUBPP0qihlUoUNVEpNUrwQEkEtbWMpTFlOoqaGKVM8CCo8T5jJ6gQLY33VYBHxIM2IBIPEhUU5Xjzx+/dYoWdgWF3u3tmnk/VW0yx7M7vZXaeffftt983cM4hIiL56VJ0ASIizUbBKyKSMwWviEjOFLwiIjlT8IqI5EzBKyKSMwWviEjOFLwiIjlT8IqI5EzBKyKSMwWviEjOFLwiIjlT8IqI5EzBKyKSs/yDNwgGEASOIBiQ+3OLiJRA16ILEGlWYZwG2HuwG7AYWJQlkTbIbgJB7huh20j3BWAgzr2Y75OL5COM042AHYHtfNsa2NS3TYD1gB5AsNynLgIWAB8B89poHwLvAXNb/sySaH4nd0c6mIJXpJ38yHUnYF9gELArsK3/8GxgBvAWFpYf+PYx8AXwJRa2awDdfVsX6Onbxq0e98SCezP/uMUCloXx3CqP38+SaEkHd19Wg4JXZDWEcbouMBj4AXAA0Ad4G3gaeMa3l7MkWtBJz98DC+HeWBBv1urx8n/X3X/aUiz0VxbSs7IkWtgZdYtR8IqsojBO1wYOAQ7HQncJ8DDwEPBglkQzCyyvTX40viHVg7nl8cb+0xzwDjZSfx14CXvPvpol0eI8629UCl6RKnxw7Qb8FDgSm5O9H7gDC9vPCyyvQ/lRdC8gZNncdD9gABbQC4HngCnAZODZLIkWFVJsnVPwirQhjNMNgGOBk4EdsLC5AbgnS6LPiqytCGGc9gYGAnsA+2NhvAB4ALgNmKTpiVWn4BVpJYzTfsDpwDHAfGA8cF2WRFmRdZVNGKc9sQAeChyMLYe7GxgHPKdlcdUpeKXp+emEvYEzsbnbJ4GrgLuyJPqyyNrqgb/QeDA2HfN97P09DviLRsFtU/BK0wrjtCtwKBa4A7ER26VZEj1TaGF1LIzT7bDpmeOx3xgS4FoF8FcpeKXphHG6DhYMZ2AXjW4ALs+S6M1CC2sgYZyuD5yG/R8vBC4G/qSLcUbBK00jjNNNgZHAqdiSqauAq7Mk+qDQwhpYGKfrYf/nZwNzgDOyJJpUbFXFU/BKwwvjdFtgNLZKYQ5wGTChGVcnFCWM002AC4ERwCRgVDP/hqHglYYVxulu2Pztj4DngUuw5WC6bbYgYZz2B34P7A5cgE3xNN30g4JXGkoYp12ACAvcPYEUC9zHtcSpHPwqkuOw3zzeAU7MkuiFQovKmYJXGoK/6+poYAywDXAzMDZLolcKLUwqCuN0M2z0exhwEXBxs4x+FbxS18I43RCbNxwFrANcA1yZJdG7hRYmqyyM08Ox1+1NYFiWRDMKLqnTKXilLoVx2he7Wv4zbIvF32HLlT4ptDBZLWGc9sGW9e2B/RC9rpGnhhS8Ujf83OA+2BtzCDANuAK4RXeY1T//+o4ExgJ3AidlSfRpsVV1DgWvlF4Yp2th87enYxuO3wtcCTzWyKOiZhXG6UDgdmz/h8OzJJpWcEkdTsErpeWnE0YAw7GDWccD47RhTePzu8ONx/Y/HgWMb6QfsgpeKRW/f8Jg7H7/A4FXgKuBGzvrNAcpJz/1cDI2nXQXMKJRph4UvFIKYZxuDpyAjW43xX7VvAZ4spFGOlK7ME4HYN8PS7Gph6kFl9RuCl4pjB/dHogF7hBgJvBH7HbeD4usTcpluamHkcD19fwDWcErufN7JxyP7Z2wCXAfFrj/yJJoaZG1SXn5qYdTgcuBW4BT6nX6ScErufBbMQ7FNsveC5gOXAfcrNGt1CKM00HY1MN8YGiWRP8quKSaKXil04Rxuga27vYY7LbQpditvNcDL9bzr4pSLH/00J+BfYHhWRLdUnBJNVHwSofzO1ANA47Cjg1/ELgJuLeRTuWVYvkNkcbgN1nH9vqti5MuFLzSIcI4/TpwBBa4O2PbMN4I3JYl0X+KrE0aWxinewG3Au9hqx7eLriklVLwymoL43RL4HDfdgMybCrhpnqcd5P6FcZpL+x779vAsVkS3VdwSVUpeKUmYZxugV0kOwLbzPod7ELH7cALmreVovhrCucD52E3XZxT1m0mFbxSlV/C8y1s/eQQbEQxi2Vh+5zCVsokjNMDsNFvBhyVJdEbxVa0IgWvrMBvKr4vFraHAFtiy7/uB/4KPKuwlTIL47Q3MAH4Hra50g1l+p5V8ErLqLYfsL9v+wA9gEexsH1AG9NIvfGrHkYBCTZgOLksJ0oreJuUvzC2Hxa0+2HLvt4CJvv2kDYVl0YQxukuwESgF7bH7z0Fl6TgbQZhnHbDlnjtDnzX/xkCHwBTsKCdolGtNCo/fXY+EGO3G4/KkuijoupR8DYYH7LbYhuGD8BCdhCwFjaifcq3J4Dp2htBmkkYp7tic78bAz/HTi/Jfe5XwVunfMBugwVs67Yd0BU7h2wa8CQ+bLMker+YakXKw49+Y+Bc4BFs7ndmnjUoeEvOb53YErD9WBaw2wPdgE+AV7ENw1u3OWW6iitSNmGc7oDtijcIuAT4bZZEn+Xx3ArekvABuzVfDdeWgO0OfErbAfuuAlZk9fiVD0dhwbsYOBO4vbPfUwrenPm7a7ZixSmC7bElXPNpO2BnK2BFOkcYp+tiUw+jgZewu94e6aznU/B2Er82dnNsNUF/374J7IAF7ALaDthZCliRYvgDVi/EtjKdDJybJdHzHf08Ct4OEMbp+lio9uerQbsh8AUWsNOBl7FwfRX4t1YUiJST39r019ht8pOAi7Mkeryjvr6CtwZ+PmgrbO+ClrYztiYW7Myw6b5N83++kSXR4tyLFZF2C+N0IHAOcCi2BPNSIM2SaEl7vm7XDqitIfmjavqzYsiui13omgZMBf7mH7/cKEdPi4jJkugFYGgYpzsCZwF3AHOAvu35uk0fvH4U+3VsqmAXloXsNkCA7XA0FZvvGesfZ5omEGkeWRK9BhwfxunZwPD2fr2mmWoI47Q7FqY7Lte2B9YGFmJTA1NbtWlZEn2cV40i0hwaZsTr18H2Ar6BzcP29a3l8RZAF2ya4DXfbmv1eKbmYkUkD6UNXr8ca22g53JtY2wnrT7LtV5YsALMxS50vQ08ju1MNBOYge7oEpGCdfpUgw/Q9fHBecpTtw8667GJ40YP/sVv7uq/3wJWDNbWrXurL+WA/wHzsGCdU6HNypJoQad2SkSkHdo14g3j9GiqB2dPYCNgjZbPeazvgCVnPTaRmT37/AQ7FXSebzOxud95FdrH7V3CISJSBu0a8YZxOofKQdlme/OSIdt0dUvrch2viEhHaJpVDSIiZdFl5f+kgzn3Is4FLaEbBEGPIAguCIKgR+61dBD1oTwaoR/qQ3l0Vj/yH/EuX0AQrI9t2r2Bc64uz/hSH8qjEfqhPpRHZ/Uj/xGviEiTU/CKiORMwSsikrMyBO8X2MbDXxRdSDuoD+XRCP1QH8qjU/pR+MU1EZFmU4YRr4hIU1HwiojkTMErIpKz3LeFDIJgHWAc8CXwqHPuZv/3PwQOArYELnLOPZ13bauqUh/8x/oDU4CtnHPzCypxpaq8DhdgG8T/F/iVc25OYUWugir96I2dlRUAtzrnniiuyuqq9OEE4DvYe2Kac+6c4qqsrkofBgPH+X92rXPuoWIqXLkqfTgSiIBFwFjn3Gvtfa4iRryHAnc654ZjJ3gC4Jy71zl3EnAesGcBddWizT4EQdANOBH4e1GF1aDNPgCLsW+8Rdg2nGVXqR9jsE3vlwKziyisBpXeE9f598QMYEJBta2qSq/DvsAZwChgcBGF1aBSHw4DTsB+kI/uiCcqIni3AGb5x1/Z5jEIgtHAFdhxymVWqQ9jgCuxvYPLrlIfLnbODQMexn6IlF2lfuyEbYB/AfDLnGuqVbX3xJpAX+fc67lXVZtKfbgVOyDyHuD6vIuqUaU+jAX+AJyCbXPbbkUE72ysgys8v3PuMuAI7CdkmVXqwy7AacAgYETeRdWozT4451oO8XwfO1G57Cq9FrOx6ZL5wJp5F1Wjiu8JYChwd77lrJZKfTgH2BvYC4jzLqpGld4Tz/rfPG5iWTC3S+7reP08ylXY4ZL/BA5yzg0LguBE7HTfDYDxzrnHcy2sBpX60OrjE4CRdTDH29brcC42p/g14HTn3HsFlrlSVfrRDzuO22Fzi2Wf423z+ykIgvuAHzvnPi+wxJWq8jochV27AZjsnJtYVI0rU6UPg4FDsIHImc65ue1+Lt1AISKSLy0nExHJmYJXRCRnCl4RkZwpeEVEcqbgFRHJmYJXRCRnCl4RkZwpeEVEcqbgFRHJmYJXRCRnCl4RkZwpeEVEcqbgFRHJmYJXRCRnCl4RkZz9H+lcpuurPuqlAAAAAElFTkSuQmCC"></td>
    </tr>
  </tbody>
</table>
</body>

</html>